![Stephen B. Solomon, MD -- Chief, Interventional Radiology Service](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/598/image/solomon-stephenmsk-030113-1051.jpg?h=10d202d3)
Stephen B. Solomon, MD
Interventional Radiologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Interventional Radiology: Tumor Ablation (Radiofrequency Ablation, Cryoablation)
Request an Appointment
About Me
- Chief, Interventional Radiology Service
- Enid A. Haupt Chair in Clinical Investigation
I am an interventional radiologist who uses x-ray, CT, ultrasound, and MRI to perform procedures less invasively. I am Chief of the Interventional Radiology Service in the Department of Radiology and also Director of Memorial Sloan Kettering’s Center for Image-Guided Interventions (CIGI). At CIGI, we are combining imaging processes and disciplines to develop and apply new image-guided cancer therapies to more effectively treat and cure disease.
Read more
Interventional radiology is an increasingly common approach to treating cancer. We use images to see the tumor and the blood vessels that supply it. These images help guide our minimally invasive tools to the site of the tumor so we can use several diagnostic and therapeutic techniques. Patients who have interventional radiological procedures do not need a large incision. They often don’t need general anesthesia. In many cases, these procedures are less risky, and recovery times are shorter than with traditional surgery.
My particular area of interest is treating tumors with thermal ablation. In this technique, we use imaging to guide a needle to a target tumor and then destroy it with either heat (radiofrequency ablation) or extreme cold (cryoablation). I treat kidney cancer, liver cancer, lung cancer, and bone cancer with these procedures. I also perform hepatic artery embolization. For this technique, we inject particles into the main blood vessel that supplies a tumor to cut off its blood supply.
Some of my current research projects involve evaluating a new ablation tool called irreversible electroporation (NanoKnife®). I am also studying using a CT-guided clinical robot to perform procedures more accurately and using PET images to monitor the health of patients who have undergone ablation. In addition, I am looking for ways to boost the immune system’s reaction to cancer cells after tumor ablation. I lead a research lab of dedicated colleagues. We work together to improve image-guided cancer interventions.
An interventional (IN-ter-VEN-shun-al) radiologist is a doctor with special training in using image-guided procedures to diagnose and treat disease.
My Specialties
- Interventional Radiology: Tumor Ablation (Radiofrequency Ablation, Cryoablation)
Education
- MD, Yale School of Medicine
Residencies
- Yale-New Haven Hospital
- The Johns Hopkins Hospital
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2012-2013, 2015-2020)
Board Certifications
- Radiology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Solomon sees patients at three locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Solomon
- A Phase II Study of LN-145 Immunotherapy in People with Metastatic Non-Small-Cell Lung Cancer
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Solomon’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Stephen B. Solomon discloses the following relationships and financial interests:
-
Advantagene, Inc.
Professional Services and Activities -
Aperture Medical Technology
Equity; Fiduciary Role / Position; Intellectual Property Rights -
GE Healthcare
Professional Services and Activities -
ImPact Biotech
Professional Services and Activities -
Innoblative Designs
Equity -
Johnson & Johnson
Equity -
Lantheus Medical Imaging, Inc.
Equity -
MEDX Xelerator LP
Professional Services and Activities (Uncompensated)
-
Merck & Co Inc.
Professional Services and Activities -
Microbot Medical Ltd.
Professional Services and Activities -
Motus GI Holdings, Inc.
Equity -
Orchestra BioMed, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Paige.AI, Inc.
Fiduciary Role / Position -
Poseida Therapeutics, Inc.
Equity -
SureFire, LLC
Equity -
XACT Robotics, Ltd.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].